Louisiana Administrative Code › Title 51 - PUBLIC HEALTH-SANITARY CODE › Part II - The Control of Diseases › Chapter 1 - Disease Reporting Requirements › Section II-107 - Laboratory and Healthcare Facility Reporting Requirements [formerly Section 113]

Current through Register Vol. 50, No. 6, June 20, 2024
A. The
				director of every laboratory and the director of an applicable healthcare
				facility whether public, private, hospital or other, within or out of the state
				shall report to the state health officer the results of all tests that are in
				any way clinically relevant, suggestive or indicative of an individual having
				active disease, past or present exposure to, past or present contact with
				and/or past or present association with any of the disease/conditions listed in
				LAC 51 (Public Health-Sanitary Code), Part II, Chapter 1,
				§105 The results of the tests to be
				reported to the state health officer do not have to be conducted for diagnostic
				reasons, nor do the results have to be diagnostic or confirmatory. The report
				shall be received in a timely manner consistent with the requirements of the
				diseases/conditions by class for the diseases/conditions described in
				§105 of this Chapter and shall state the
				name, date of birth, sex, race, usual residence, pregnancy status of the
				individual (if the pregnancy status is known and if it is clinically relevant
				to the disease or condition being reported), specimen identification code/ID
				and test results of the tested individual as well as the name of the physician
				or person submitting the specimen. Contact information for the laboratory or an
				applicable healthcare facility performing the test(s) shall be provided.
				Laboratories or an applicable healthcare facility shall not defer their public
				health reporting responsibilities to any other authorities within the
				institutions they serve. In addition, laboratories or an applicable healthcare
				facility performing tests on specimens received from other laboratories or an
				applicable healthcare facility shall report to the state health officer all
				results as prescribed above plus the contact information for the
				facility/laboratory or an applicable healthcare facility where the specimen
				originated. Moreover, no considerations, evaluations or concerns, regarding any
				test technology or test result by institutions and/or organizations whether
				federal, state or otherwise
(e.g.,
FDA, CMS-CLIA, etc.) which
				may be overseeing, approving, evaluating or licensing laboratory testing, shall
				represent an
a priori
rationale for withholding laboratory
				reports from the state health officer.
B. All laboratory facilities shall, in
				addition to reporting tests indicative of conditions found in §105, report
				positive or suggestive results for additional conditions of public health
				interest. The following findings shall be reported as detected by laboratory
				facilities:
1. adenoviruses;
2. coronaviruses;
3. enteroviruses;
4. hepatitis B (carriage, other than in
				pregnancy);
5. hepatitis C (past or
				present infection), including genotype where available;
6. human metapneumovirus;
7. parainfluenza viruses;
8. respiratory syncytial virus; and
9. rhinoviruses.